4ᵗʰ International Symposium on Radiobiology of Targeted Radionuclide Therapy

22 and 23 April 2027

Pavilhão de Portugal, Universidade de Lisboa
Portugal

About the Event

The Centro de Ciências e Tecnologias Nucleares of Instituto Superior Técnico, Universidade de Lisboa, is delighted to host the ‘4ᵗʰ International Symposium on Radiobiology of Targeted Radionuclide Therapy’.

This meeting is held once every two years on behalf of the European Working Group on the Radiobiology of Targeted Radionuclide Therapy (https://www.mrtradiobiology.com/). After the successful editions of the  International Workshop on Radiobiology of Molecular Radiotherapy in Montpellier, London and Rotterdam, it is with  great enthusiasm that we  invite you  to Lisboa for RB-TRT 2027. 

This symposium will provide a valuable platform for presentation of research on radiobiology of TRT, with inputs from rabiobiology of external beam radiotherapy, dosimetry, and other relevant areas to the field.  We invite trainees, students, professionals, and experts to exchange ideas, discuss the latest developments, and explore the future of the radiobiology of targeted radionuclide therapy.

Abstracts Submission

Submit your abstract to RB-TRT 2027!

We look forward to receiving your contributions! Abstract submissions will be open from 16 November 2026 to 15 January 2027.

Submitting your abstract is easy:

STEP 1: Prepare your abstract using the template available here:

Abstract Template

STEP 2: Send your completed abstract to abstracts@rb-trt2027.pt.

The file should be saved as: author.rbtrt2027.docx.

We look forward to welcoming your work to RB-TRT 2027!

Registration

Register for RB-TRT 2027!

Join us at RB-TRT 2027! To complete your registration, simply fill out the registration form here (available soon).

Registration Fees

Registration is open from 10 December 2026 to 5 March 2027.

We look forward to welcoming you to RB-TRT 2027!

Event Schedule

To be announced soon!

Meet the invited Speakers

Department of Cancer and Genomic Sciences
School of Physics and Astronomy
University of Birmingham, United Kingdom

Group Leader, Tumour and Microenvironment Interactions
i3S – Institute for Research and Innovation in Health
University of Porto, Portugal

Professor of Multimodal Imaging and Theranostics
Department of Nuclear Medicine
University Hospital Würzburg, Germany
Cancer Development and Innate Immune Evasion Group Leader
Champalimaud Centre for the Unknown
Champalimaud Foundation, Lisbon, Portugal

About the Organisers

Filipa Mendes, António Paulo e Francisca Santos

C²TN – Centro de Ciências e Tecnologias Nucleares,                                    Instituto Superior Técnico, Universidade de Lisboa, Portugal

Organised by

Host Institution

Our Sponsors